In a report released today, Jessica Tassan from Piper Sandler reiterated a Hold rating on Premier (PINC – Research Report), with a price target of $24.00. The company’s shares closed yesterday at $21.53.
According to TipRanks, Tassan is a 3-star analyst with an average return of 4.0% and a 50.53% success rate. Tassan covers the Healthcare sector, focusing on stocks such as Health Catalyst, CVS Health, and Evolent Health.
In addition to Piper Sandler, Premier also received a Hold from Barclays’s Stephanie Davis in a report issued yesterday. However, today, Benchmark Co. reiterated a Buy rating on Premier (NASDAQ: PINC).
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $32.65 and a one-year low of $18.70. Currently, Premier has an average volume of 939K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Premier (PINC) Company Description:
Premier, Inc. operates as a holding company with interests in health services. It specializes in data and analytics, supply chain solutions, advisory and other services. It operates through the Supply Chain Services and Performance Services segments. The Supply Chain Services segment offers products and services such as group purchasing, specialty pharmacy, direct sourcing, managed services, and Software-as-a-Service Informatics products. The Performance Services segment provides information technology analytics, and workflow automation and advisory services. The company was founded on May 14, 2013 and is headquartered in Charlotte, NC.
Read More on PINC:
